BioCentury
ARTICLE | Financial News

Antiva Biosciences completes venture financing

March 31, 2017 5:17 AM UTC

On March 28, HPV play Antiva Biosciences Inc. (Menlo Park, Calif.) raised $22 million in a series C round led by new investor Brace Pharma Capital. New investors NS Investment, Osage University Partn...

BCIQ Company Profiles

Antiva Biosciences Inc.